Navigation Links
In-hospital formula use deters breastfeeding
Date:2/14/2014

al breastfed group had stopped breastfeeding.

Perhaps most significant, in-hospital formula feeding dramatically reduced the likelihood of later fully breastfeeding as well as any breastfeeding, even after adjusting for the strength of the mothers' intention to continue these practices. Early formula use nearly doubled the risk of formula use from the first to the second month and nearly tripled the risk of ending all breastfeeding by the end of the second month.

The study also found that breastfeeding deterrence was dose dependent. In other words, the more formula given to babies during their hospital stay, the less likely the mother would continue breastfeeding. This is the first time researchers have found a relationship between in-hospital formula doses and breastfeeding behavior.

Mothers indicated a number of reasons for giving their babies formula in the hospital. Many thought they weren't producing enough milk. Some thought their babies weren't getting enough nutrition or were not latching on properly. Chantry notes that sometimes formula is medically necessary and research is needed to better understand how to minimize its negative effects on breastfeeding.

Chantry believes this research highlights the value of The Ten Steps to Successful Breastfeeding evidence-based guidelines to help mothers breastfeed. These include educating women about the benefits of breastfeeding, teaching them how to breastfeed and limiting formula use unless medically necessary.

"These results underline the importance of providing comprehensive support for women who wish to breastfeed," says Chantry. "Doctors and nurses must be trained to help, and lactation consultants must be readily available. We need to do more to help mothers overcome breastfeeding obstacles and limit formula use."

Breastfeeding exclusively rather than using infant formula is recommended for the first six months after birth by the American Academy o
'/>"/>

Contact: Tricia Tomiyoshi
tricia.tomiyoshi-marsom@ucdmc.ucdavis.edu
916-734-9706
University of California - Davis Health System
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A touch of garlic helps kill contaminants in baby formula
2. DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
3. Xyngular Announces the Launch of its New Xyng Enhanced Formula
4. Formula-feeding linked to metabolic stress and increased risk of later disease
5. New formula invented for microscope viewing, substitutes for federally controlled drug
6. New, cost-cutting approach to formulating pest-killing fungi
7. UC Riverside developing biofuel formulations for California
8. Breast milk promotes a different gut flora growth than infant formulas
9. Maths formula leads researchers to source of pollution
10. Liquid glucagon formulation discovered for potential use in artificial pancreas systems
11. Hazelnuts improve infant formula
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... Liver transplant patients with hepatitis C virus (HCV) ... the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination ... virus in vitro. , The results of ... of Liver Transplantation, the official journal of the ...
... infants born with HIV infection may be most effective ... according to a study published in the April 1 ... online. , Uncertainty over when to start antiretroviral treatment ... around balancing the benefits of preventing disease progression and ...
... in which single strands of synthetic DNA are used ... been developed by researchers with the Lawrence Berkeley National ... Berkeley. This technique holds promise for a wide ... of artificial tissues and the design of neural networks. ...
Cached Biology News:Cyclosporine inhibits hepatitis C virus in vitro 2New study shows benefit of early therapy in HIV-infected infants 2Berkeley researchers lay groundwork for cell version of DNA chip 2Berkeley researchers lay groundwork for cell version of DNA chip 3Berkeley researchers lay groundwork for cell version of DNA chip 4
(Date:4/21/2015)... April 21, 2015 Progyny, Inc., the ... LLC, announced that it has secured additional capital from ... Biotech, SR One and Merck Serono Ventures. The funding ... patients the best fertility outcomes by aligning science, technology, ... online marketplace for families seeking fertility solutions and we ...
(Date:4/21/2015)... April 21, 2015 YourEncore, an ... life sciences, consumer products and food sciences industries ... the Alliance for Clinical Research Excellence and Safety ... for conducting clinical research, have partnered to speed ... , YourEncore brings to ACRES experts with ...
(Date:4/20/2015)... Texas , April 20, 2015 ... surgeons for healing bone injuries. The orthobiologics market is ... opportunities for its stakeholders. The global orthobiologics market report ... forecast of revenue. The global orthobiologics market was valued ... reach $7,900.2 million by 2019, at a CAGR of ...
(Date:4/20/2015)... , April 20, 2015  "Everybody is affected ... do to patients is frankly brutal. We,ve got to ... a cancer ward, or witnessed a loved one or ... witnessed firsthand the devastation chemotherapy and other treatments cause ... people want to give up and succumb to the ...
Breaking Biology Technology:Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3Is Dr. Craig Dionne the Steve Jobs of Cancer Research? 2
... DENVER , Aug. 5 Forensic Laboratories, ... for drug and alcohol abuse, has announced the expansion ... the first lab in the nation to develop an ... saliva, a chemical produced by the body after alcohol ...
... KANSAS CITY, Kansas , Aug. 5 Oncimmune® ... test that aids physicians in risk assessment and the early ... study that demonstrates the clinical validity of the test. The study ... Diagnosis " is now available on line at Annals of ...
... reveal how a new type of experimental antibiotic ... existing treatments [1]. The findings could ultimately help ... bacteria responsible for many hospital and community-acquired infections. ... a team of researchers from GlaxoSmithKline (GSK) captured ...
Cached Biology Technology:Forensic Laboratories Develops First Oral Fluid Test for Ethyl Sulfate Detection 2New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 2New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 3New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 4New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 5New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 6Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance 2
... Glutamate receptors constitute the principal ... Two classes of glutamate receptors ... receptors. Ionotropic glutamate receptors are ... (GluR1-7, NMDA1-3, KAI-2) which comprise ...
Recommended fro Western blotting application...
... 15 (KLF15) KLF15 is a Cys2-His2 ... expressed in the liver, kidneys, heart, and ... Specificity: Polyclonal antibody produced in rabbits immunized ... region of human KLF15 with an internal ...
... was developed in the late 1960s by ... the earliest commercial pioneers of immunoassay in ... in 1987. Sac-Cel rapidly found favour with ... "in house" radioimmunoassays, and became a benchmark ...
Biology Products: